Draft:Gufic Biosciences
 | This is a draft article. It is a work in progress open to editing by anyone. Please ensure core content policies are met before publishing it as a live Wikipedia article. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Last edited by Thilsebatti (talk | contribs) 1 second ago. (Update)
Finished drafting? |
| Company type | Public |
|---|---|
| NSE: GUFICBIO, BSE: 509079[1] | |
| Industry | Pharmaceuticals |
| Founded | 1970 (group); incorporated 23 December 1984 (as public company).[2][3] |
| Founder | Late Shri Pannalal Choksi[2] |
| Headquarters | Mumbai, Maharashtra, India.[4] |
Area served | Worldwide |
Key people | Jayesh P. Choksi (Chairman and Managing Director); Pranav J. Choksi (Chief Executive Officer).[5] |
| Products | Active pharmaceutical ingredients, injectables, formulations |
| Website | gufic |
Gufic Biosciences Limited is an Indian pharmaceutical company that manufactures active pharmaceutical ingredients, generic formulations and lyophilised injectable products. The Gufic group traces its origins to 1970; Gufic Biosciences was incorporated as a public company in 1984 and is headquartered in Mumbai, Maharashtra.[2][3] The company is listed on the National Stock Exchange and the Bombay Stock Exchange.[1]
References
- ^ a b "Gufic Biosciences Limited - Quote & Overview". NSE India. Retrieved 8 August 2025.
- ^ a b c "About Us". Gufic Group. Retrieved 8 August 2025.
- ^ a b "GUFIC BIOSCIENCES LIMITED (CIN: L24100MH1984PLC033519)". ZaubaCorp. Retrieved 8 August 2025.
- ^ "Gufic Biosciences Ltd Company Profile". Moneycontrol. Retrieved 8 August 2025.
- ^ "Board of Directors". Gufic Group. Retrieved 8 August 2025.
This page will be placed in the following categories if it is moved to the article namespace.
Categories: - Pharmaceutical companies of India
- Companies listed on the National Stock Exchange of India
- Companies listed on the Bombay Stock Exchange